Literature DB >> 8243821

Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy.

V Spallone1, L Bernardi, L Ricordi, P Soldà, M R Maiello, A Calciati, S Gambardella, P Fratino, G Menzinger.   

Abstract

In diabetic autonomic neuropathy, abnormal circadian patterns of blood pressure and sympathovagal balance with reduced fall of blood pressure and prevalence of sympathetic activity during the night have been described. To correlate the abnormalities of blood pressure to those of sympathovagal balance, we simultaneously performed 24-h noninvasive monitoring of blood pressure and ECG in 25 diabetic patients (45.6 +/- 13.6 yr of age with a 17.6 +/- 9.1 yr duration of diabetes) with various degrees of cardiovascular reflex impairment. Autoregressive power spectrum analysis of RR interval variability was applied to 24-h ECG recordings to obtain for day and night periods the mean power of low- (0.03-0.15 Hz) and high-frequency (0.18-0.40 Hz) components, which are relative markers of sympathetic and vagal activity, respectively, and their ratio (low frequency/high frequency), assumed as index of sympathovagal balance. Diabetic patients showed a lower percentage of day-night change in systolic blood pressure (9 +/- 5.48 vs. 11.6 +/- 4.78%, P < 0.037), a lower day low frequency (5.9 +/- 0.81 vs. 6.62 +/- 0.73 In-ms2, P < 0.001), a lower night high frequency (6.06 +/- 0.71 vs. 6.52 +/- 0.85 In-ms2, P < 0.05), a lower day low frequency:high frequency ratio (1.82 +/- 1.77 vs. 3.05 +/- 1.82, P < 0.01), and a lower percentage of day-night change in low-frequency:high frequency ratio (-13.4 +/- 109.9 vs. 28.7 +/- 29.7%, P < 0.05), when compared with control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8243821     DOI: 10.2337/diab.42.12.1745

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 2.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

Review 3.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

4.  Differential impact of type-1 and type-2 diabetes on control of heart rate in mice.

Authors:  Catherine L Stables; David S Auerbach; Steven E Whitesall; Louis G D'Alecy; Eva L Feldman
Journal:  Auton Neurosci       Date:  2015-12-17       Impact factor: 3.145

5.  Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy.

Authors:  D Ziegler; D Laude; F Akila; J L Elghozi
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

6.  [Heart failure. Cardiovascular autonomic neuropathy in patients with diabetes mellitus].

Authors:  B Bellmann; C Tschöpe
Journal:  Herz       Date:  2014-05       Impact factor: 1.443

7.  Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients.

Authors:  Alfredo Costa; Daniele Bosone; Matteo Cotta Ramusino; Natascia Ghiotto; Elena Guaschino; Annalisa Zoppi; Angela D'Angelo; Roberto Fogari
Journal:  Clin Auton Res       Date:  2016-09-13       Impact factor: 4.435

Review 8.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

9.  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Authors:  Mai Yanagi; Kouichi Tamura; Tetsuya Fujikawa; Hiromichi Wakui; Tomohiko Kanaoka; Masato Ohsawa; Kengo Azushima; Akinobu Maeda; Hiroyuki Kobori; Satoshi Umemura
Journal:  Hypertens Res       Date:  2012-11-15       Impact factor: 3.872

10.  Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.